118 related articles for article (PubMed ID: 18344434)
1. Estimation of the beta+ dose to the embryo resulting from 18F-FDG administration during early pregnancy.
Zanotti-Fregonara P; Champion C; Trébossen R; Maroy R; Devaux JY; Hindié E
J Nucl Med; 2008 Apr; 49(4):679-82. PubMed ID: 18344434
[TBL] [Abstract][Full Text] [Related]
2. In vivo quantification of 18f-fdg uptake in human placenta during early pregnancy.
Zanotti-Fregonara P; Jan S; Champion C; Trébossen R; Maroy R; Devaux JY; Hindié E
Health Phys; 2009 Jul; 97(1):82-5. PubMed ID: 19509511
[TBL] [Abstract][Full Text] [Related]
3. Absorbed 18F-FDG dose to the fetus during early pregnancy.
Zanotti-Fregonara P; Jan S; Taieb D; Cammilleri S; Trébossen R; Hindié E; Mundler O
J Nucl Med; 2010 May; 51(5):803-5. PubMed ID: 20395321
[TBL] [Abstract][Full Text] [Related]
4. SUV correction for injection errors in FDG-PET examination.
Miyashita K; Takahashi N; Oka T; Asakawa S; Lee J; Shizukuishi K; Inoue T
Ann Nucl Med; 2007 Dec; 21(10):607-13. PubMed ID: 18092139
[TBL] [Abstract][Full Text] [Related]
5. Tumor blood flow measured by PET dynamic imaging of first-pass 18F-FDG uptake: a comparison with 15O-labeled water-measured blood flow.
Mullani NA; Herbst RS; O'Neil RG; Gould KL; Barron BJ; Abbruzzese JL
J Nucl Med; 2008 Apr; 49(4):517-23. PubMed ID: 18344436
[TBL] [Abstract][Full Text] [Related]
6. Assessment of human biodistribution and dosimetry of 4-fluoro-11beta-methoxy-16alpha-18F-fluoroestradiol using serial whole-body PET/CT.
Beauregard JM; Croteau E; Ahmed N; van Lier JE; Bénard F
J Nucl Med; 2009 Jan; 50(1):100-7. PubMed ID: 19091905
[TBL] [Abstract][Full Text] [Related]
7. Technologist radiation exposure in routine clinical practice with 18F-FDG PET.
Guillet B; Quentin P; Waultier S; Bourrelly M; Pisano P; Mundler O
J Nucl Med Technol; 2005 Sep; 33(3):175-9. PubMed ID: 16145226
[TBL] [Abstract][Full Text] [Related]
8. Standardized uptake values of uterine leiomyoma with 18F-FDG PET/CT: variation with age, size, degeneration, and contrast enhancement on MRI.
Kitajima K; Murakami K; Yamasaki E; Kaji Y; Sugimura K
Ann Nucl Med; 2008 Jul; 22(6):505-12. PubMed ID: 18670857
[TBL] [Abstract][Full Text] [Related]
9. Breast cancer with low FDG uptake: characterization by means of dual-time point FDG-PET/CT.
Zytoon AA; Murakami K; El-Kholy MR; El-Shorbagy E; Ebied O
Eur J Radiol; 2009 Jun; 70(3):530-8. PubMed ID: 18395387
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of dual-time-point 18F-FDG PET for staging in patients with lung cancer.
Uesaka D; Demura Y; Ishizaki T; Ameshima S; Miyamori I; Sasaki M; Fujibayashi Y; Okazawa H
J Nucl Med; 2008 Oct; 49(10):1606-12. PubMed ID: 18794269
[TBL] [Abstract][Full Text] [Related]
11. Estimated radiation dose to the newborn in FDG-PET studies.
Ruotsalainen U; Suhonen-Polvi H; Eronen E; Kinnala A; Bergman J; Haaparanta M; Teräs M; Solin O; Wegelius U
J Nucl Med; 1996 Feb; 37(2):387-93. PubMed ID: 8667081
[TBL] [Abstract][Full Text] [Related]
12. [Toxicity and radiation dosage of 2-(18F)-2-desoxy-D-glucose in positron emission tomography].
Ruhlmann J; Oehr P; Bender H; Kozak B; Willkomm P; Bechtold V; Lind P; Biersack HJ
Acta Med Austriaca; 1998; 25(1):1-6. PubMed ID: 9576017
[TBL] [Abstract][Full Text] [Related]
13. Assessment of interobserver reproducibility in quantitative 18F-FDG PET and CT measurements of tumor response to therapy.
Jacene HA; Leboulleux S; Baba S; Chatzifotiadis D; Goudarzi B; Teytelbaum O; Horton KM; Kamel I; Macura KJ; Tsai HL; Kowalski J; Wahl RL
J Nucl Med; 2009 Nov; 50(11):1760-9. PubMed ID: 19837757
[TBL] [Abstract][Full Text] [Related]
14. Fetal Radiation Dose from 18F-FDG in Pregnant Patients Imaged with PET, PET/CT, and PET/MR.
Zanotti-Fregonara P; Laforest R; Wallis JW
J Nucl Med; 2015 Aug; 56(8):1218-22. PubMed ID: 26089550
[TBL] [Abstract][Full Text] [Related]
15. Fetal and maternal absorbed dose estimates for positron-emitting molecular imaging probes.
Xie T; Zaidi H
J Nucl Med; 2014 Sep; 55(9):1459-66. PubMed ID: 25024424
[TBL] [Abstract][Full Text] [Related]
16. Giant cell arteritis on 18F-FDG PET/CT.
Heston TF; Szabo Z
Clin Physiol Funct Imaging; 2009 Sep; 29(5):382-4. PubMed ID: 19522856
[TBL] [Abstract][Full Text] [Related]
17.
Ahmadi N; Karimian A; Nasrabadi MN
J Med Signals Sens; 2022; 12(2):171-175. PubMed ID: 35755983
[TBL] [Abstract][Full Text] [Related]
18. New Fetal Dose Estimates from 18F-FDG Administered During Pregnancy: Standardization of Dose Calculations and Estimations with Voxel-Based Anthropomorphic Phantoms.
Zanotti-Fregonara P; Chastan M; Edet-Sanson A; Ekmekcioglu O; Erdogan EB; Hapdey S; Hindie E; Stabin MG
J Nucl Med; 2016 Nov; 57(11):1760-1763. PubMed ID: 27261522
[TBL] [Abstract][Full Text] [Related]
19. The feasibility of 11C-methionine-PET in diagnosis of solitary lung nodules/masses when compared with 18F-FDG-PET.
Hsieh HJ; Lin SH; Lin KH; Lee CY; Chang CP; Wang SJ
Ann Nucl Med; 2008 Jul; 22(6):533-8. PubMed ID: 18670862
[TBL] [Abstract][Full Text] [Related]
20. Idiopathic pulmonary fibrosis and diffuse parenchymal lung disease: implications from initial experience with 18F-FDG PET/CT.
Groves AM; Win T; Screaton NJ; Berovic M; Endozo R; Booth H; Kayani I; Menezes LJ; Dickson JC; Ell PJ
J Nucl Med; 2009 Apr; 50(4):538-45. PubMed ID: 19289428
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]